Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Pfizer Inc. | 31 | 4 | 3 | 0 | €26.38 | €41.10 | 55.841% |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 5 | 0 | €905.80 | €957.22 | 5.677% |
| Elanco Animal Health Inc. | 7 | 3 | 1 | 0 | €15.78 | €15.58 | -1.235% |
| Biogen Inc. | 46 | 1 | 6 | 1 | €208.90 | €294.01 | 40.742% |
| Amgen Inc. | 25 | 0 | 5 | 0 | €285.95 | €297.31 | 3.973% |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €62.61 | €86.77 | 38.590% |
| AbbVie Inc. | 21 | 0 | 4 | 0 | €149.46 | €174.43 | 16.709% |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €122.15 | €130.00 | 6.427% |
| Eli Lilly Corp. | 50 | 0 | 5 | 0 | €702.50 | €766.92 | 9.169% |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | €120.00 | €124.93 | 4.108% |
| Abbott Laboratories | 16 | 0 | 2 | 0 | €97.12 | €116.81 | 20.272% |
| Vertex Pharmaceuticals Inc. | 45 | 2 | 7 | 0 | €398.60 | €406.87 | 2.074% |
| Zoetis Inc. A | 23 | 1 | 5 | 0 | €155.66 | €200.06 | 28.522% |
| Johnson & Johnson | 32 | 1 | 3 | 0 | €140.18 | €196.74 | 40.345% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 3 | 0 | €76.16 | €102.62 | 34.741% |